Why is Fredun Pharma falling/rising?

As of 18-Sep, Fredun Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 1,250.00, reflecting a decrease of 5.0 points or 0.4%. Today's price summary indicates that the stock has underperformed its sector by 1.45% and has fallen after three consecutive days of gains, touching an intraday low of Rs 1216.1. Despite a strong performance over the past month with an 18.40% increase and a remarkable year-to-date return of 69.55%, the stock's recent movement is influenced by a significant drop in investor participation, with delivery volume falling by 40.29% compared to the five-day average. Although the company has shown healthy long-term growth with net sales increasing at an annual rate of 38.16% and positive results for the last five consecutive quarters, the lack of domestic mutual fund investment may signal caution among institutional investors.
In the broader market context, while the stock has outperformed the benchmark Sensex over the past year with a return of 60.93% compared to the Sensex's 0.08%, it has underperformed in the short term, with a 1.63% increase over the last week versus the Sensex's 1.80% gain. This discrepancy highlights the stock's volatility and the potential impact of recent trading activity and investor sentiment on its price movement. The stock's liquidity remains adequate for trading, but the recent trend reversal and declining investor engagement may contribute to its current downward trajectory.